Anúncio
Anúncio
CTXR
Citius Pharmaceuticals Inc. Common
0.88
USDPatrocinado
-0.02
-2.56%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
0.87
-0.01
-0.80%
Relatórios de Lucros CTXR
Rácio de surpresa positiva
CTXR separação 9 de 26 últimas estimativas.
35%
Próximo Relatório
Data do Próximo Relatório
12 de fev. de 2026
Estimate for Q1 26 (Revenue/ EPS)
$3.52M
/-$0.01
Mudanças implicadas de Q4 25 (Revenue/ EPS)
--
/--
Mudanças implicadas de Q1 25 (Revenue/ EPS)
--
/-99.23%
Citius Pharmaceuticals Inc. Common earnings per share and revenue
On 26 de dez. de 2025, CTXR reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.49 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 5.87 milhão, with a -100.00% difference. The market reacted with a -1.69% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analistas forecast an EPS of -0.01 USD, with revenue projected to reach 3.52 milhão USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Citius Pharmaceuticals Inc. Common's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Citius Pharmaceuticals Inc. Common reported EPS of --, missing estimates by --, and revenue of $0.00, -100% below expectations.
How did the market react to Citius Pharmaceuticals Inc. Common's Q4 2025 earnings?
The stock price moved down -1.69%, changed from $0.84 before the earnings release to $0.83 the day after.
When is Citius Pharmaceuticals Inc. Common expected to report next?
The next earning report is scheduled for 12 de fev. de 2026.
What are the forecasts for Citius Pharmaceuticals Inc. Common's next earnings report?
Based on 3
analistas, Citius Pharmaceuticals Inc. Common is expected to report EPS of -$0.01 and revenue of $3.52M for Q1 2026.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio